Skip to content
PICO Portalanswers from OpenAlex

Budesonide/formoterol maintenance and reliever therapy via <scp>T</scp>urbuhaler versus fixed‐dose budesonide/formoterol plus terbutaline in patients with asthma: Phase <scp>III</scp> study results

PaperCitations, authors & open-access status

Budesonide/formoterol maintenance and reliever therapy via <scp>T</scp>urbuhaler versus fixed‐dose budesonide/formoterol plus terbutaline in patients with asthma: Phase <scp>III</scp> study results is a paper indexed in PICO Portal from OpenAlex.

How many citations does Budesonide/formoterol maintenance and reliever therapy via <scp>T</scp>urbuhaler versus fixed‐dose budesonide/formoterol plus terbutaline in patients with asthma: Phase <scp>III</scp> study results have?

PICO Portalcitation count

Budesonide/formoterol maintenance and reliever therapy via <scp>T</scp>urbuhaler versus fixed‐dose budesonide/formoterol plus terbutaline in patients with asthma: Phase <scp>III</scp> study results has 40 citations in the OpenAlex counts PICO Portal stores.

When was Budesonide/formoterol maintenance and reliever therapy via <scp>T</scp>urbuhaler versus fixed‐dose budesonide/formoterol plus terbutaline in patients with asthma: Phase <scp>III</scp> study results published?

PICO Portalyear

Budesonide/formoterol maintenance and reliever therapy via <scp>T</scp>urbuhaler versus fixed‐dose budesonide/formoterol plus terbutaline in patients with asthma: Phase <scp>III</scp> study results has 2012 year in the PICO Portal index.

What is the open-access status of Budesonide/formoterol maintenance and reliever therapy via <scp>T</scp>urbuhaler versus fixed‐dose budesonide/formoterol plus terbutaline in patients with asthma: Phase <scp>III</scp> study results?

PICO Portaloa status

Budesonide/formoterol maintenance and reliever therapy via <scp>T</scp>urbuhaler versus fixed‐dose budesonide/formoterol plus terbutaline in patients with asthma: Phase <scp>III</scp> study results has closed oa status in the PICO Portal index.

What is the DOI of Budesonide/formoterol maintenance and reliever therapy via <scp>T</scp>urbuhaler versus fixed‐dose budesonide/formoterol plus terbutaline in patients with asthma: Phase <scp>III</scp> study results?

PICO Portaldoi

The DOI for Budesonide/formoterol maintenance and reliever therapy via <scp>T</scp>urbuhaler versus fixed‐dose budesonide/formoterol plus terbutaline in patients with asthma: Phase <scp>III</scp> study results is on the source record.

What is the PMID of Budesonide/formoterol maintenance and reliever therapy via <scp>T</scp>urbuhaler versus fixed‐dose budesonide/formoterol plus terbutaline in patients with asthma: Phase <scp>III</scp> study results?

PICO Portalpmid

The PMID for Budesonide/formoterol maintenance and reliever therapy via <scp>T</scp>urbuhaler versus fixed‐dose budesonide/formoterol plus terbutaline in patients with asthma: Phase <scp>III</scp> study results is on the source record.

What is the OpenAlex record for Budesonide/formoterol maintenance and reliever therapy via <scp>T</scp>urbuhaler versus fixed‐dose budesonide/formoterol plus terbutaline in patients with asthma: Phase <scp>III</scp> study results?

PICO Portalopenalex

The OpenAlex for Budesonide/formoterol maintenance and reliever therapy via <scp>T</scp>urbuhaler versus fixed‐dose budesonide/formoterol plus terbutaline in patients with asthma: Phase <scp>III</scp> study results is on the source record.

Related on PICO Portal

470M+ articles · 14-day free trial